Delivery Order SPE2DB25D3012-SPE2DB25FWYSD
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $3,261.55 for Pediarix 0.5 ML syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 mL syringes, valued at $2,797.02 under firm fixed pricing. This non-competitive delivery order, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract utilizes AmerisourceBergen's existing indefinite delivery contract vehicle with the DLA, enabling rapid fulfillment...
- The Defense Logistics Agency awarded a $10,577.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Pediarix 0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will take place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $5,151.24 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pediarix 0.5 ML syringes. This non-set-aside, firm fixed price contract is classified as a delivery order and has an ultimate completion date of July 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,166.15 firm fixed price delivery order for Pediarix 0.5 mL syringes, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $29,016.40, is for the supply of 0.5 mL Pediarix syringes, which are used to administer a pediatric vaccine. The contract has a firm-fixed price pricing type and a completion date of September 4, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,299.69 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a $23,085.29 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 mL syringes. The contract has an ultimate completion date of May 17, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of a larger...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYSDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,253.00 to supply Pediarix 0.5 ML syringes. This contract, which is not set-aside, was competitively awarded with a firm fixed price structure and an ultimate completion date of July 21, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a wide range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. Through this vehicle, the company serves multiple government healthcare customers including the Defense Health Agency and the U.S. Coast Guard, positioning it as a key provider within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/18/25 |